Anti-CD70 [LD70]
AB03947-3.0
ApplicationsELISA, Neutralisation/Blocking
Product group Antibodies
ReactivityHuman
TargetCD70
Overview
- SupplierAbsolute Antibody
- Product NameAnti-CD70 [LD70]
- Delivery Days Customer9
- Antibody SpecificityThis antibody binds human CD70, a cytokine belonging to the tumor necrosis factor (TNF) ligand family, which acts as a ligand for TNFRSF27/CD27. It is a surface antigen present on activated T and B cells. The CD70-CD27 pathway plays an important role in t
- Application Supplier NoteThis antibody block the binding of CD70 to CD21. This blocking effect was tested using the scFv version and it was reported that it was capable of blocking the binding of recombinant CD70-Fc to CD21 coated on ELISA plates. This antibody was also reported to have inhibitory effect on the growth of breast cancer cells in vitro. The in vivo inhibitory activity of this antibody was tested in mice infected with breast cancer cells MDA-MB-231. It was further reported that this antibody could inhibit tumor growth in vivo (CN109021106).
- ApplicationsELISA, Neutralisation/Blocking
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone IDLD70
- Gene ID970
- Target nameCD70
- Target descriptionCD70 molecule
- Target synonymsCD27 ligand; CD27L; CD27-L; CD27LG; CD70 antigen; Ki-24 antigen; LPFS3; surface antigen CD70; TNFSF7; TNLG8A; tumor necrosis factor ligand 8A; tumor necrosis factor ligand superfamily member 7
- HostMouse
- IsotypeIgG2b
- Protein IDP32970
- Protein NameCD70 antigen
- ReactivityHuman
- Storage Instruction-20°C,2°C to 8°C
- UNSPSC12352203